Company intelligence / Profile preview

Spiration

Redmond, Washington, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

The Spiration Valve System (SVS), a minimally invasive bronchoscopic device, is FDA-approved (breakthrough device) for severe emphysema. Clinical results from the EMPROVE trial demonstrated statistically significant improvements in lung function and quality of life; the system is commercially available in the U.S., EU, Australia, and New Zealand.[2][4]

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Olympus Medical Systems (exclusive distributor and acquirer)[1]Imbio (AI CT analysis for patient selection)[3]

Beyond the preview

Go deeper on Spiration.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spiration.

Explore the full profile